|
|
Volumn 13, Issue 2, 2002, Pages 327-330
|
|
Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairment
a
|
|
Author keywords
Delayed excretion; Methotrexate; Nephrotoxicity; Vancomycin
|
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
CEFEPIME;
CISPLATIN;
CYTOTOXIC AGENT;
DOXORUBICIN;
FOLINIC ACID;
GENTAMICIN;
IFOSFAMIDE;
METHOTREXATE;
ORAL CONTRACEPTIVE AGENT;
PENTETIC ACID;
POLYPEPTIDE ANTIBIOTIC AGENT;
TECHNETIUM 99M;
VANCOMYCIN;
ARTICLE;
CANCER CHEMOTHERAPY;
CASE REPORT;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG EXCRETION;
DRUG EXPOSURE;
DRUG MEGADOSE;
FEBRILE NEUTROPENIA;
FEMUR TUMOR;
FEVER;
GLOMERULUS FILTRATION RATE;
HUMAN;
KIDNEY DISEASE;
KIDNEY SCINTISCANNING;
MEDICAL ASSESSMENT;
MEDICAL DOCUMENTATION;
MUCOSA INFLAMMATION;
NEPHROTOXICITY;
OSTEOSARCOMA;
PANCYTOPENIA;
PRIORITY JOURNAL;
SEPTICEMIA;
ADULT;
ANTI-BACTERIAL AGENTS;
ANTIMETABOLITES, ANTINEOPLASTIC;
BONE NEOPLASMS;
DRUG INTERACTIONS;
FEMALE;
GLOMERULAR FILTRATION RATE;
HUMANS;
KIDNEY;
KIDNEY DISEASES;
MALE;
METABOLIC CLEARANCE RATE;
METHOTREXATE;
OSTEOSARCOMA;
VANCOMYCIN;
|
|
EID: 0036302672
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdf021 Document Type: Article |
|
Times cited : (25)
|
|
References (11)
|
